Search Results - "Popovic, Djordje S"

Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus? by Popovic, Djordje S., Stoian, Anca Pantea, Papanas, Nikolaos

Get full text

Ezetimibe and Insulin Resistance by Popovic, Djordje S, Papachristou, Stella, Stokic, Edita, Papanas, Nikolaos

Get more information

The importance of sleep quality, quantity, and chronotype in the management of diabetes: Is it time to wake up? by Koufakis, Theocharis, Maltese, Giuseppe, Popovic, Djordje S., Kotsa, Kalliopi

Get full text

Achieving LDL-cholesterol Targets: How Good are we in the Balkan Region? by Popovic, Djordje S, Stokic, Edita, Stoian, Anca Pantea, Papanas, Nikolaos

Get more information

A Mediterranean Eating Pattern Combining Energy and Time-Restricted Eating Improves Vaspin and Omentin Concentrations Compared to Intermittent Fasting in Overweight Individuals by Karras, Spyridon N, Koufakis, Theocharis, Popovic, Djordje S, Adamidou, Lilian, Karalazou, Paraskevi, Thisiadou, Katerina, Zebekakis, Pantelis, Makedou, Kali, Kotsa, Kalliopi

“…Athonian Orthodox fasting (AOF) is characterized by energy- and time-restricted eating (TRE) and is based on the Mediterranean diet. We aimed to investigate…”
Get full text

Changes in dietary intake of aspartic acid during and after intermittent fasting correlate with an improvement in fasting glucose in overweight individuals by Karras, Spyridon N., Koufakis, Theocharis, Dimakopoulos, Georgios, Popovic, Djordje S., Kotsa, Kalliopi

“…Highlights We investigated a potential correlation between amino acid intake and glycemic markers among individuals who practiced intermittent fasting and…”
Get full text

Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas by Papantoniou, Eleni, Arvanitakis, Konstantinos, Markakis, Konstantinos, Papadakos, Stavros P, Tsachouridou, Olga, Popovic, Djordje S, Germanidis, Georgios, Koufakis, Theocharis, Kotsa, Kalliopi

“…Infections with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) represent one of the greatest health burdens worldwide. The…”
Get full text

GLP-1 Receptor Agonists and Type 1 Diabetes - Where Do We Stand? by Popovic, Djordje S, Stokic, Edita, Popovic, Stevan L

“…Type 1 diabetes (T1DM) is a disease characterized by autoimmune mediated destruction of the insulin producing beta cells of endocrine pancreas. Beside insulin…”
Get more information

1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity by Popovic, Djordje S, Tomic-Naglic, Dragana, Mitrovic, Milena, Zivanovic, Zeljko, Vukovic, Bojan, Stokic, Edita

“…Current data show that 1h oral glucose tolerance test (OGTT) blood glucose (1h-BG) might identify persons at increased risk of developing type 2 diabetes and…”
Get more information

The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity by Popovic, Djordje S, Mitrovic, Milena, Tomic-Naglic, Dragana, Icin, Tijana, Bajkin, Ivana, Vukovic, Bojan, Benc, Damir, Zivanovic, Zeljko, Kovacev-Zavisic, Branka, Stokic, Edita

“…Sclerostin is an inhibitor of the wingless-type mouse mammary tumor virus integration site family/β-catenin signalling pathway (WβcSP), which plays an…”
Get more information

Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity by Popovic, Djordje S, Stokic, Edita, Mitrovic, Milena, Tomic-Naglic, Dragana, Pejin, Radoslav, Icin, Tijana, Vukovic, Bojan, Zivanovic, Zeljko, Pejakovic, Sladjana, Kovacev-Zavisic, Branka

“…Obesity is often associated with insulin resistance (IR). We considered different IR indexes: the Homeostasis Model Assessment-Insulin Resistance (HOMA-IR)…”
Get more information

Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons by Koufakis, Theocharis, Popovic, Djordje S, Papanas, Nikolaos

Get more information

The new dual gastric inhibitory peptide/glucagon‐like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright? by Papachristou, Stella, Popovic, Djordje S., Papanas, Nikolaos

“…Tirzepatide is a dual gastric inhibitory peptide/glucagon‐like peptide 1 (GIP/GLP‐1) receptor agonist formulated as a synthetic linear peptide, based on the…”
Get full text

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes by Popovic, Djordje S., Patoulias, Dimitrios, Karakasis, Paschalis, Koufakis, Theocharis, Papanas, Nikolaos

Get full text

Contrast-Associated Acute Kidney Injury: More Frequent Among Patients With Diabetic Foot Ulcers by Popovic, Djordje S., Papanas, Nikolaos

Get full text

Double Diabetes: A Growing Problem Requiring Solutions by Popovic, Djordje S, Papanas, Nikolaos

“…The growing proportion of type 1 diabetes mellitus (T1DM) patients with clinical features of insulin resistance (IR) has led to the description of a…”
Get more information

SGLT2 inhibitors: A groundbreaking class of cardiovascular drugs, but who benefits most? by Koufakis, Theocharis, Popovic, Djordje S., Maltese, Giuseppe, Papanas, Nikolaos

Get full text

Are SGLT-2 inhibitors “the elephant in the room” of non-diabetic glomerulonephritis? Considerations about the background immunosuppressive treatment by Patoulias, Dimitrios, Popovic, Djordje S.

Get full text

Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes by Popovic, Djordje S., Patoulias, Dimitrios, Gnudi, Luigi, Mantzoros, Christos S.

Get full text

Beta-Catenin Signaling Pathway: Perhaps We Should Start Exploring it for Diabetic Foot Ulcer Healing? by Papanas, Nikolaos, Popovic, Djordje S.

“…Diabetic foot ulcers (DFUs) remain a common debilitating and costly complication of diabetes mellitus. Indeed, despite all efforts and emerging technologies,…”
Get full text